دورية أكاديمية
أعرض في EDS

Hemostasis Strategies and Recent Advances in Nanomaterials for Hemostasis.

التفاصيل البيبلوغرافية
العنوان: Hemostasis Strategies and Recent Advances in Nanomaterials for Hemostasis.
المؤلفون: Du J; Suining Municipal Hospital of Traditional Chinese Medicine, Suining 629000, China., Wang J; Suining Municipal Hospital of Traditional Chinese Medicine, Suining 629000, China., Xu T; Suining Municipal Hospital of Traditional Chinese Medicine, Suining 629000, China., Yao H; Center For Peak of Excellence on Biological Science and Food Engineering, National University of Singapore (Suzhou) Research Institute, Suzhou 215004, China., Yu L; Center For Peak of Excellence on Biological Science and Food Engineering, National University of Singapore (Suzhou) Research Institute, Suzhou 215004, China., Huang D; College of Biological Science and Engineering, Fuzhou University, Fuzhou 350108, China.
المصدر: Molecules (Basel, Switzerland) [Molecules] 2023 Jul 07; Vol. 28 (13). Date of Electronic Publication: 2023 Jul 07.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049 (Electronic) Linking ISSN: 14203049 NLM ISO Abbreviation: Molecules Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI, c1995-
مواضيع طبية MeSH: Hemostatics*/pharmacology , Nanostructures*/therapeutic use, Humans ; Hemostasis ; Wound Healing ; Hemorrhage/drug therapy
مستخلص: The development of materials that effectively stop bleeding and prevent wound adhesion is essential in both military and medical fields. However, traditional hemostasis methods, such as cautery, tourniquets, and gauze, have limitations. In recent years, new nanomaterials have gained popularity in medical and health fields due to their unique microstructural advantages. Compared to traditional materials, nanomaterials offer better adhesion, versatility, and improved bioavailability of traditional medicines. Nanomaterials also possess advantages such as a high degree and stability, self-degradation, fewer side effects, and improved wound healing, which make them ideal for the development of new hemostatic materials. Our review provides an overview of the currently used hemostatic strategies and materials, followed by a review of the cutting-edge nanomaterials for hemostasis, including nanoparticles and nanocomposite hydrogels. The paper also briefly describes the challenges faced by the application of nanomaterials for hemostasis and the prospects for their future development.
References: Blood Coagul Fibrinolysis. 2002 Sep;13(6):489-96. (PMID: 12192300)
J Conserv Dent. 2021 May-Jun;24(3):260-264. (PMID: 35035151)
Nanoscale. 2022 Aug 4;14(30):10738-10749. (PMID: 35866631)
VideoGIE. 2021 Jun 22;6(10):481-483. (PMID: 34660948)
J Thromb Haemost. 2018 Jun;16(6):1226-1235. (PMID: 29573326)
Acta Biomater. 2022 Dec;154:49-62. (PMID: 36265792)
Front Bioeng Biotechnol. 2021 Nov 22;9:780187. (PMID: 34881238)
Platelets. 2021 Jul 4;32(5):651-661. (PMID: 32668997)
Nanoscale Res Lett. 2013 Feb 22;8(1):102. (PMID: 23432972)
Biomacromolecules. 2014 Apr 14;15(4):1484-90. (PMID: 24694012)
Biomaterials. 2004 Nov;25(26):5681-703. (PMID: 15147815)
Adv Healthc Mater. 2019 Dec;8(23):e1900823. (PMID: 31697456)
ACS Nano. 2020 Jun 23;14(6):6649-6662. (PMID: 32469498)
Pharmaceutics. 2022 Dec 28;15(1):. (PMID: 36678736)
Circ Rep. 2021 Sep 9;3(12):691-698. (PMID: 34950794)
Methods Mol Biol. 2018;1682:103-124. (PMID: 29039097)
Crit Rev Biochem Mol Biol. 2015;50(4):326-36. (PMID: 26018600)
Hamostaseologie. 2015;35(1):11-6. (PMID: 25666572)
J Mater Chem B. 2019 Aug 21;7(33):5096-5103. (PMID: 31432879)
ACS Nano. 2012 Mar 27;6(3):1883-7. (PMID: 22414146)
ACS Appl Mater Interfaces. 2018 Mar 7;10(9):7717-7729. (PMID: 29461041)
Front Bioeng Biotechnol. 2021 Feb 02;8:627351. (PMID: 33604331)
J Hepatobiliary Pancreat Surg. 2000;7(1):58-62. (PMID: 10982593)
Adv Mater. 2017 Feb;29(8):. (PMID: 27966826)
Int J Pharm. 2010 Mar 15;387(1-2):187-98. (PMID: 19969054)
Acta Biomater. 2019 Jan 15;84:63-76. (PMID: 30471475)
Int Braz J Urol. 2002 Nov-Dec;28(6):504-9. (PMID: 15748397)
Arterioscler Thromb Vasc Biol. 2007 Aug;27(8):1687-93. (PMID: 17556654)
ACS Biomater Sci Eng. 2015;1(12):1300-1305. (PMID: 26753175)
ACS Nano. 2016 Jan 26;10(1):899-909. (PMID: 26700464)
BJOG. 2015 Jan;122(2):202-10. (PMID: 25289730)
Trauma Mon. 2016 Feb 06;21(1):e26023. (PMID: 27218055)
Res Pract Thromb Haemost. 2021 Jul 14;5(5):e12548. (PMID: 34278188)
Nat Commun. 2019 Dec 5;10(1):5562. (PMID: 31804481)
Adv Healthc Mater. 2018 Apr;7(7):e1701086. (PMID: 29334429)
Biomacromolecules. 2016 Aug 8;17(8):2572-81. (PMID: 27405511)
J Biomed Mater Res B Appl Biomater. 2021 Oct;109(10):1465-1477. (PMID: 33511753)
Carbohydr Polym. 2021 Aug 1;265:118043. (PMID: 33966826)
J Knee Surg. 2022 Oct;35(12):1378-1384. (PMID: 33607677)
Biomater Sci. 2021 Dec 21;10(1):10-50. (PMID: 34775503)
J Am Acad Dermatol. 2013 Nov;69(5):659.e1-659.e17. (PMID: 24124834)
J Vet Emerg Crit Care (San Antonio). 2022 Jan;32(S1):63-71. (PMID: 35044067)
Adv Healthc Mater. 2021 Oct;10(20):e2100918. (PMID: 34235873)
Bioact Mater. 2022 Jun 14;20:355-367. (PMID: 35784635)
Handb Exp Pharmacol. 2012;(210):3-22. (PMID: 22918725)
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Sep;9(5):. (PMID: 28078811)
Curr Med Chem. 2016;23(5):408-30. (PMID: 26063498)
Lancet. 2012 Sep 22;380(9847):1099-108. (PMID: 22998719)
Int J Biol Macromol. 2019 May 15;129:936-943. (PMID: 30738162)
Nanoscale. 2020 Jul 23;12(28):14976-14995. (PMID: 32644089)
ACS Appl Mater Interfaces. 2017 Nov 22;9(46):40107-40116. (PMID: 29091393)
Catheter Cardiovasc Interv. 2021 Aug 1;98(2):E181-E187. (PMID: 33655650)
Biomaterials. 2013 Apr;34(12):3031-41. (PMID: 23357371)
Int J Biol Macromol. 2022 Jun 1;209(Pt A):50-58. (PMID: 35331795)
Biomaterials. 2018 Oct;179:46-59. (PMID: 29980074)
Ann Transl Med. 2021 Apr;9(7):577. (PMID: 33987275)
Polymers (Basel). 2021 Oct 29;13(21):. (PMID: 34771308)
Biomaterials. 2019 Jun;204:70-79. (PMID: 30901728)
Biomacromolecules. 2015 Oct 12;16(10):3112-8. (PMID: 26348089)
PLoS One. 2018 Jul 19;13(7):e0199911. (PMID: 30024907)
J Periodontol. 2006 Apr;77(4):545-64. (PMID: 16584335)
Vascul Pharmacol. 2018 Feb;101:1-8. (PMID: 29174014)
Asian J Endosc Surg. 2022 Apr;15(2):376-379. (PMID: 34734488)
J Foot Ankle Surg. 1995 May-Jun;34(3):236-46. (PMID: 7550186)
Front Physiol. 2018 Jan 30;9:41. (PMID: 29441026)
Int J Biol Macromol. 2020 Jul 15;155:71-80. (PMID: 32217121)
Cardiovasc Diagn Ther. 2017 Dec;7(Suppl 3):S267-S275. (PMID: 29399530)
معلومات مُعتمدة: 2019J05031 Natural Science Foundation of Fujian Province
فهرسة مساهمة: Keywords: effective hemostasis; hemostasis strategies; nanomaterials; nanotechnology; wound healing
المشرفين على المادة: 0 (Hemostatics)
تواريخ الأحداث: Date Created: 20230714 Date Completed: 20230717 Latest Revision: 20230718
رمز التحديث: 20240514
مُعرف محوري في PubMed: PMC10343471
DOI: 10.3390/molecules28135264
PMID: 37446923
قاعدة البيانات: MEDLINE
الوصف
تدمد:1420-3049
DOI:10.3390/molecules28135264